Intracerebral hemorrhage secondary prevention: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 24: Line 24:
* In AF patients with warfarin-associated lobar ICH or suspected [[Cerebral amyloid angiopathy|CAA]], the risk ICH recurrence seems higher than [[Thromboembolic event|thromboembolic events]]. Therefore, the best management is to discontinue [[Warfarin|warfarin therapy.]]
* In AF patients with warfarin-associated lobar ICH or suspected [[Cerebral amyloid angiopathy|CAA]], the risk ICH recurrence seems higher than [[Thromboembolic event|thromboembolic events]]. Therefore, the best management is to discontinue [[Warfarin|warfarin therapy.]]


*In patients with lobar ICH and [[CHADS2 score]] ≥5
*In patients with lobar ICH and [[CHA2DS2-VASc Score|CHADS2 VASc score]] > 5
** LAA closure is a viable option  
** [[Left atrial appendage|LAA closure]] is a viable option  
**If LAA is not feasible [[Oral anticoagulation therapy|oral anticoagulation (OAC)]] is considered
**If [[Left atrial appendage|LAA]] is not feasible [[Oral anticoagulation therapy|oral anticoagulation (OAC)]] is considered
**The use of DOACS (e.g. [[Apixaban]]) might be an alternative to [[warfarin]]
**The use of DOACS (e.g. [[Apixaban]]) might be an alternative to [[warfarin]]
*In warfarin-related ICH patients with [[prosthetic valves]]
*In warfarin-related ICH patients with [[prosthetic valves]]

Revision as of 16:25, 1 December 2016

Intracerebral hemorrhage Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Stroke from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Emergency Diagnosis and Assessment

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Other Imaging Findings

Treatment

Early Assessment

Management

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

AHA/ASA Guidelines for the Management of Spontaneous Intracerebral Hemorrhage (2015)

Management of ICH

AHA/ASA Guideline Recommendation for the Primary Prevention of Stroke (2014)

Primary Prevention of Stroke

Case Studies

Case #1

Intracerebral hemorrhage secondary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Intracerebral hemorrhage secondary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Intracerebral hemorrhage secondary prevention

CDC on Intracerebral hemorrhage secondary prevention

Intracerebral hemorrhage secondary prevention in the news

Blogs on Intracerebral hemorrhage secondary prevention

Directions to Hospitals Treating Stroke

Risk calculators and risk factors for Intracerebral hemorrhage secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mehrsefat, M.D. [2]

Overview

Secondary prevention

Life style modification

Life style modification measures which may help reduce the risk of intracerebral hemorrhage recurrent may include:

  • Eating healthy balanced diet
  • Smoking cessation
  • Decreased alcohal intake
  • Improved support from health care providers & care takers
  • Patient education (involvement in BP monitoring to improve adherence to therapy)

Prevention of recurrent ICH

Blood pressure control

Receive early treatment targeted to an SBP level <140 mmHg to improve the chances of achieving better functional recovery

Restarting anticoagulation

Restarting anticoagulation should be avoided, UNLESS the risk of ischemic stroke is MUCH HIGHER than that of recurrent ICH.

  • In patients with lobar ICH and CHADS2 VASc score > 5
  • In warfarin-related ICH patients with prosthetic valves
  • The optimal time to resumption of anticoagulation after warfarin-related ICH is unclear and may vary from patient to patient
  • Avoidance of oral anticoagulation (OAC) for 4-8 weeks, in patients without mechanical heart valves, might decrease the risk of ICH recurrence

Prevention of complications

The preventive measures which may help prevent complications of intracerebral hemorrhage include:[1]

  • Use of intermittent pneumatic compression begun as early as the day of hospital admission 
  • Prophylactic anticonvulsant medication has not been demonstrated to be beneficia. However, in a case of clinical seizures or electrographic seizures in patients with a change in mental status should be treated with antisezure drugs to prevent recurrence
  • Proper positioning of patient, and the use of thick feed with the help of nasogastric tube for feeding to prevent aspiration pneumonia in patients with cranial nerve palsies affecting pharyngeal motility and gag reflex
  • Pressure ulcers may be prevented by use of air mattress and regular change in position of patient

References


Template:WS Template:WH